Catalyst Pharmaceuticals, Inc. (CPRX) SEC Filings — 2025
20 SEC filings for Catalyst Pharmaceuticals, Inc. (CPRX) in 2025.
Filings
- Catalyst Pharma Soars: Revenue Up 25%, Net Income Jumps 50% — 10-Q · Nov 5, 2025
- Catalyst Pharmaceuticals Files 8-K — 8-K · Oct 1, 2025
- Catalyst Pharmaceuticals Files 8-K/A Amendment — 8-K/A · Aug 28, 2025
- Catalyst Pharmaceuticals Files 8-K — 8-K · Aug 25, 2025
- Catalyst Pharmaceuticals Files 8-K — 8-K · Aug 7, 2025
- Catalyst Pharmaceuticals Files 8-K — 8-K · Aug 6, 2025
- Catalyst Pharma Sees Q2 Revenue Jump 7.1% on Product Sales — 10-Q · Aug 6, 2025
- Catalyst Pharmaceuticals Files 8-K: Director Changes & Officer Compensation — 8-K · Aug 4, 2025
- Catalyst Pharmaceuticals Files 8-K — 8-K · Jun 2, 2025
- Catalyst Pharmaceuticals Files 8-K on Director, Officer, and Compensation Changes — 8-K · May 23, 2025
- Catalyst Pharmaceuticals Files 8-K — 8-K · May 7, 2025
- Catalyst Pharmaceuticals Files Q1 2025 10-Q — 10-Q · May 7, 2025
- Catalyst Pharmaceuticals Files 2025 DEF 14A — DEF 14A · Apr 11, 2025
- Catalyst Pharmaceuticals Files 8-K — 8-K · Apr 9, 2025
- Catalyst Pharmaceuticals Files 8-K — 8-K · Feb 26, 2025
- Catalyst Pharmaceuticals Files 2024 10-K — 10-K · Feb 26, 2025
- Catalyst Pharmaceuticals Appoints New Director — 8-K · Jan 24, 2025
- Catalyst Pharmaceuticals Files 8-K — 8-K · Jan 21, 2025
- Catalyst Pharmaceuticals Files 8-K — 8-K · Jan 13, 2025
- Catalyst Pharmaceuticals Files 8-K — 8-K · Jan 8, 2025